Showing 1 - 4 results of 4 for search 'Valeria Cervoni', query time: 0.06s Refine Results
  1. 1
    Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature

    Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature by Ottavia Bernocchi, Marianna Sirico, Silvia Paola Corona, Carla Strina, Manuela Milani, Maria Rosa Cappelletti, Giuseppina Ferrero, Nicoletta Ziglioli, Valeria Cervoni, Andrea Macchiavelli, Giandomenico Roviello, Daniele Generali

    Published 2021-02-01
    Get full text
    Article
  2. 2
    Early Changes of the Standardized Uptake Values (SUV<sub>max</sub>) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

    Early Changes of the Standardized Uptake Values (SUV<sub>max</sub>) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cance... by Marianna Sirico, Ottavia Bernocchi, Navid Sobhani, Fabiola Giudici, Silvia P. Corona, Claudio Vernieri, Federico Nichetti, Maria Rosa Cappelletti, Manuela Milani, Carla Strina, Valeria Cervoni, Giuseppina Barbieri, Nicoletta Ziglioli, Martina Dester, Giulia Valeria Bianchi, Filippo De Braud, Daniele Generali

    Published 2020-11-01
    Get full text
    Article
  3. 3
    Computational reactive–diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving Olaparib

    Computational reactive–diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving Olaparib by Francesco Schettini, Maria Valeria De Bonis, Carla Strina, Manuela Milani, Nicoletta Ziglioli, Sergio Aguggini, Ignazio Ciliberto, Carlo Azzini, Giuseppina Barbieri, Valeria Cervoni, Maria Rosa Cappelletti, Giuseppina Ferrero, Marco Ungari, Mariavittoria Locci, Ida Paris, Giovanni Scambia, Gianpaolo Ruocco, Daniele Generali

    Published 2023-07-01
    Get full text
    Article
  4. 4
    Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial

    Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial by Francesco Schettini, Francesco Schettini, Silvia Paola Corona, Silvia Paola Corona, Fabiola Giudici, Fabiola Giudici, Carla Strina, Marianna Sirico, Ottavia Bernocchi, Ottavia Bernocchi, Manuela Milani, Nicoletta Ziglioli, Sergio Aguggini, Carlo Azzini, Giuseppina Barbieri, Valeria Cervoni, Maria Rosa Cappelletti, Alfredo Molteni, Maria Chiara Lazzari, Giuseppina Ferrero, Marco Ungari, Elena Marasco, Alice Bruson, Luciano Xumerle, Elisa Zago, Davide Cerra, Marco Loddo, Gareth H. Williams, Ida Paris, Ida Paris, Giovanni Scambia, Giovanni Scambia, Daniele Generali, Daniele Generali

    Published 2021-06-01
    Get full text
    Article

Search Tools: